Sandra Franco

4.5k total citations
77 papers, 2.2k citations indexed

About

Sandra Franco is a scholar working on Oncology, Hepatology and Molecular Biology. According to data from OpenAlex, Sandra Franco has authored 77 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 26 papers in Hepatology and 20 papers in Molecular Biology. Recurrent topics in Sandra Franco's work include Hepatitis C virus research (25 papers), HER2/EGFR in Cancer Research (19 papers) and Cancer Treatment and Pharmacology (16 papers). Sandra Franco is often cited by papers focused on Hepatitis C virus research (25 papers), HER2/EGFR in Cancer Research (19 papers) and Cancer Treatment and Pharmacology (16 papers). Sandra Franco collaborates with scholars based in Spain, United States and Colombia. Sandra Franco's co-authors include Miguel Ángel Martı́nez, Bonaventura Clotet, Cristina Tural, Charles L. Vogel, Stephen Johnston, Kimberly Blackwell, Allison Florance, Mariona Parera, María Nevot and Lisa O’Rourke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Sandra Franco

77 papers receiving 2.2k citations

Peers

Sandra Franco
Megan Wind‐Rotolo United States
Pil Soo Sung South Korea
William L. Ince United States
Daniel M. Jones United States
Zenta Tsuchihashi United States
Teresa Cabezón Denmark
Premal H. Patel United States
Julio Gutiérrez United States
Seng‐Lai Tan United States
Takasuke Fukuhara Japan
Megan Wind‐Rotolo United States
Sandra Franco
Citations per year, relative to Sandra Franco Sandra Franco (= 1×) peers Megan Wind‐Rotolo

Countries citing papers authored by Sandra Franco

Since Specialization
Citations

This map shows the geographic impact of Sandra Franco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Franco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Franco more than expected).

Fields of papers citing papers by Sandra Franco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Franco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Franco. The network helps show where Sandra Franco may publish in the future.

Co-authorship network of co-authors of Sandra Franco

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Franco. A scholar is included among the top collaborators of Sandra Franco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Franco. Sandra Franco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franco, Sandra, Lourdes Mateu, Raquel Pluvinet, et al.. (2024). Altered Plasma microRNA Signature in Hospitalized COVID-19 Patients Requiring Oxygen Support. Microorganisms. 12(3). 440–440. 4 indexed citations
2.
Fein, Luis, Nicolas Lazaretti, John R. Benfield, et al.. (2023). Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate. Clinical Drug Investigation. 43(9). 699–706. 3 indexed citations
3.
Dawood, Shaheenah, Rebecca Dent, Sung‐Bae Kim, et al.. (2021). Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting. BMC Proceedings. 15(S10). 15–15. 2 indexed citations
4.
Franco, Sandra, et al.. (2021). Impact of Synonymous Genome Recoding on the HIV Life Cycle. Frontiers in Microbiology. 12. 606087–606087. 10 indexed citations
5.
Soldevila, Laura, Jordi Bechini, Juan J. López-Núñez, et al.. (2019). Association Between Visceral Abdominal Fat Accumulation and Severity of Liver Fibrosis in Nondiabetic Individuals Coinfected by Human Immunodeficiency Virus and Hepatitis C Virus. AIDS Research and Human Retroviruses. 36(3). 205–213. 2 indexed citations
6.
Franco, Sandra, Raquel Pluvinet, Beatriz Mothe, et al.. (2018). Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures. Antiviral Research. 155. 106–114. 9 indexed citations
7.
Bellacasa, Raimon Puig de la, Sandra Franco, Roger Badía, et al.. (2016). Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors. European Journal of Medicinal Chemistry. 115. 463–483. 16 indexed citations
8.
9.
Franco, Sandra, María Casadellà, Marc Noguera-Julián, et al.. (2013). No detection of the NS5B S282T mutation in treatment-naïve genotype 1 HCV/HIV-1 coinfected patients using deep sequencing. Journal of Clinical Virology. 58(4). 726–729. 14 indexed citations
10.
11.
Franco, Sandra, Núria Cañete, Montserrat Garcı́a-Retortillo, et al.. (2011). Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors. Journal of Viral Hepatitis. 18(10). e578–e582. 12 indexed citations
12.
Schwartzberg, Lee S., Sandra Franco, Allison Florance, et al.. (2010). Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor–Positive Metastatic Breast Cancer. The Oncologist. 15(2). 122–129. 158 indexed citations
13.
Rixe, Olivier, Sandra Franco, Denise A. Yardley, et al.. (2009). A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 64(6). 1139–1148. 43 indexed citations
14.
Franco, Sandra, et al.. (2007). Genetic and catalytic efficiency structure of an HCV protease quasispecies†. Hepatology. 45(4). 899–910. 30 indexed citations
15.
Franco, Sandra, Bonaventura Clotet, & Miguel Ángel Martı́nez. (2007). A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals. Virus Research. 131(2). 260–270. 13 indexed citations
16.
Rugo, Hope S., Emma Shtivelman, Alejandra Perez, et al.. (2006). Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Research and Treatment. 105(1). 17–28. 84 indexed citations
17.
Franco, Sandra, Daniel Fuster, Ramón Planas, et al.. (2004). Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection. AIDS. 18(1). 59–66. 39 indexed citations
18.
Vogel, Charles L. & Sandra Franco. (2003). Clinical Experience with Trastuzumab (Herceptin). The Breast Journal. 9(6). 452–462. 54 indexed citations
19.
Giménez‐Barcons, Mireia, Sandra Franco, Yanette Suárez, et al.. (2001). High Amino Acid Variability Within the Ns5a of Hepatitis C Virus (Hcv) Is Associated With Hepatocellular Carcinoma in Patients With Hcv–1B-Related Cirrhosis. Hepatology. 34(1). 158–167. 41 indexed citations
20.
Kohn, Elise C., Ronald G. Steis, E. A. Sausville, et al.. (1990). Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.. Journal of Clinical Oncology. 8(1). 155–160. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan Wind‐Rotolo Breakdown of academic impact, for papers by Pil Soo Sung Breakdown of academic impact, for papers by William L. Ince Breakdown of academic impact, for papers by Daniel M. Jones Breakdown of academic impact, for papers by Zenta Tsuchihashi Breakdown of academic impact, for papers by Teresa Cabezón Breakdown of academic impact, for papers by Premal H. Patel Breakdown of academic impact, for papers by Julio Gutiérrez Breakdown of academic impact, for papers by Seng‐Lai Tan Breakdown of academic impact, for papers by Takasuke Fukuhara
Rankless by CCL
2026